The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 109.50
Ask: 110.50
Change: 1.00 (0.91%)
Spread: 1.00 (0.913%)
Open: 110.00
High: 112.00
Low: 109.50
Prev. Close: 109.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification and public disclosure of LTIP

27 Feb 2018 17:02

RNS Number : 1428G
McBride PLC
27 February 2018
 

RNS Announcement

 

 

Notification and public disclosure of LTIP Awards to Directors and Persons Discharging Managerial Responsibilities ("PDMR")

 

 

27 February 2018

 

 

McBride plc confirms that awards of shares have vested under the terms of the McBride plc 2014 Long Term Incentive Plan (the Plan) to Directors as set out below.

 

The awards were vested at the end of a three-year period in accordance with the achievement of performance targets set out in the Plan, and will not require any payment from the individuals. The awards represent the net number of shares due after the addition of dividend shares and the appropriate tax and sale fees were taken into account.

 

Name

Status

No. of shares subject to vesting

 

No. of shares sold to cover taxes and fees

No. of shares retained net of taxes and fees

Rik De Vos

Chief Executive Officer

 

Director

206,054

69,167

136,887

Chris Smith

Chief Finance Officer

 

Director

154,540

72,779

81,761

 

These awards were satisfied by the transfer of 360,594 treasury shares. Following this, the number of ordinary shares of 10 pence each with voting rights is 182,569,903.

 

Following the awards, total holding and interests of the Directors in ordinary shares in McBride plc are:

 

Name

Total holdings of ordinary shares

Percentage of current issued share capital (excluding treasury shares)

Total interest in ordinary shares

Rik De Vos

176,887

0.097%

960,031

Chris Smith

122,772

0.067%

585,504

 

This announcement and the following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation.

 

1.

Details of the Persons Discharging Managerial Responsibilities ("PDMR")/Relevant Employees/Person Closely Associated ("PCA")

a)

Name

 

Rik De Vos

2.

Reason for the notification

b)

Position/Status

Chief Executive Officer

 

 

c)

Initial notification/amendment

 

Initial Notification

 

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

McBride plc

b)

LEI

213800HX7FMPA2CIEF02

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of 10p each

 

 

GB0005746358

 

 

 

b)

Nature of the transaction

 

Vesting of an award under the Company's Long Term Incentive Plan as a conditional award of shares.

 

 

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

Nil

 

192,123 - Number of shares vesting

 

13,931 - Number of shares awarded at vesting in lieu of dividends paid during vesting period.

 

136,887 - Number of shares acquired after reduction for appropriate tax and national insurance liabilities and sale fees

 

d)

Aggregated information

Aggregated volume

Price

 

As above

e)

Date of the transaction

 

23 February 2018

 

f)

Place of transaction

 

Outside of a trading venue

 

1.

Details of the Persons Discharging Managerial Responsibilities ("PDMR")/Relevant Employees/Person Closely Associated ("PCA")

a)

Name

 

Chris Smith

2.

Reason for the notification

b)

Position/Status

Chief Financial Officer

 

 

c)

Initial notification/amendment

 

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

McBride plc

b)

LEI

213800HX7FMPA2CIEF02

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of 10p each

 

 

GB0005746358

 

 

 

b)

Nature of the transaction

 

Vesting of an award under the Company's Long Term Incentive Plan as a conditional award of shares.

 

 

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

Nil

 

144,092 - Number of shares vesting

 

10,448 - Number of shares awarded at vesting in lieu of dividends paid during vesting period.

 

81,761* - Number of shares acquired after reduction for appropriate tax and national insurance liabilities and sale fees.

 

*20,000 shares allocated to PCA as notified below.

d)

Aggregated information

Aggregated volume

Price

 

As above

e)

Date of the transaction

 

23 February 2018

 

f)

Place of transaction

 

Outside of a trading venue

 

 

 

 

1.

Details of the Persons Discharging Managerial Responsibilities ("PDMR")/Relevant Employees/Person Closely Associated ("PCA")

a)

Name

 

Harriet Smith

2.

Reason for the notification

b)

Position/Status

PCA of Chris Smith, Chief Financial Officer

 

 

c)

Initial notification/amendment

 

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

McBride plc

b)

LEI

213800HX7FMPA2CIEF02

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of 10p each

 

 

GB0005746358

 

 

 

b)

Nature of the transaction

 

Vesting of an award under the Company's Long Term Incentive Plan as a conditional award of shares.

 

 

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

Nil

 

20,000 - Number of shares vesting

 

*20,000 shares allocated from Chris Smith vesting.

 

d)

Aggregated information

Aggregated volume

Price

 

As above

e)

Date of the transaction

 

23 February 2018

 

f)

Place of transaction

 

Outside of a trading venue

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSEUFMWFASEIE
Date   Source Headline
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.